Literature DB >> 21196295

KHYG-1 and NK-92 represent different subtypes of LFA-1-mediated NK cell adhesiveness.

Garnet Suck1, Suet-Mien Tan, Sixian Chu, Madelaine Niam, Ardcharaporn Vararattanavech, Tsyr Jong Lim, Mickey B C Koh.   

Abstract

Novel cancer cellular therapy approaches involving long-term ex vivo IL-2 stimulated highly cytotoxic natural killer (NK) cells are emerging. However, adhesion properties of such NK cells are not very well understood. Herein, we describe the novel observation of permanently activated alphaLbeta2 integrin leukocyte function-associated antigen (LFA)-1 adhesion receptor in long-term IL-2 activated NK cells and the permanent NK cell lines KHYG-1 and NK-92. We show that such cytokine activated NK effectors constitutively adhered to the LFA-1-ligand ICAM-1, whereas binding to the lower affinity ligand ICAM-3 required additional exogenous activating conditions. The results demonstrate an extended conformation and an intermediate affinity state for the LFA-1 population expressed by the NK cells. Interestingly, adhesion to ICAM-1 or K562 induced pronounced cell spreading in KHYG-1, but not in NK-92, and partially in long-term IL-2 stimulated primary NK cells. It is conceivable that such differential adhesion characteristics may impact motility potential of such NK effectors with relevance to clinical tumor targeting. KHYG-1 could be a useful model in planning future targeted therapeutic approaches involving NK effectors with augmented functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196295     DOI: 10.2741/e230

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  3 in total

Review 1.  Natural Killer Cells for Therapy of Leukemia.

Authors:  Garnet Suck; Yeh Ching Linn; Torsten Tonn
Journal:  Transfus Med Hemother       Date:  2016-03-22       Impact factor: 3.747

2.  NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway.

Authors:  Taiga Seki; Yui Shimizu; Kyota Ishii; Yuzuki Takahama; Kazunori Kato; Tomohiro Yano
Journal:  Biomolecules       Date:  2021-11-16

3.  CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an "Off the Shelf" Therapy for Multiple Myeloma.

Authors:  Arwen Stikvoort; Jort van der Schans; Subhashis Sarkar; Renée Poels; Ruud Ruiter; Jyoti Naik; Huipin Yuan; Joost D de Bruijn; Niels W C J van de Donk; Sonja Zweegman; Maria Themeli; Richard Groen; Michael O'Dwyer; Tuna Mutis
Journal:  Hemasphere       Date:  2021-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.